1,147
Participants
Start Date
June 19, 2012
Primary Completion Date
June 26, 2017
Study Completion Date
June 26, 2017
Secukinumab (AIN457)
"Secukinumab is a new type of psoriasis medication called a human monoclonal antibody. Monoclonal antibodies are proteins that recognize and bind to unique proteins that your body produces. Secukinumab binds and reduces the activity of a cytokine (a messenger protein in the body) called Interleukin 17 (IL-17). IL-17 is believed to be partly responsible for inflammation (pain, swelling, redness). Researchers believe that IL-17 causes symptoms of plaque-type psoriasis like plaques and scales. A product that targets IL-17 therefore may help to relieve these symptoms and conditions."
Placebo
Placebo
Novartis Investigative Site, Kopavogur
Novartis Investigative Site, Riga
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Kogarah
Novartis Investigative Site, East Melbourne
Novartis Investigative Site, Carlton
Novartis Investigative Site, Miskolc
Novartis Investigative Site, Liège
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Woolloongabba
Novartis Investigative Site, Kaposvár
Novartis Investigative Site, Ghent
Novartis Investigative Site, Szombathely
Novartis Investigative Site, Taipei
Novartis Investigative Site, New York
Novartis Investigative Site, Berlin
Novartis Investigative Site, Tallinn
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Tallinn
Novartis Investigative Site, Martigues
Novartis Investigative Site, Marseille
Novartis Investigative Site, Rochester
Novartis Investigative Site, Duncansville
Novartis Investigative Site, Greifswald
Novartis Investigative Site, Schwerin
Novartis Investigative Site, Philadelphia
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Norfolk
Novartis Investigative Site, Kiel
Novartis Investigative Site, High Point
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Charleston
Novartis Investigative Site, Snellville
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Bielefeld
Novartis Investigative Site, Daejeon
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Nashville
Novartis Investigative Site, Kingsport
Novartis Investigative Site, Louisville
Novartis Investigative Site, Louisville
Novartis Investigative Site, Taichung
Novartis Investigative Site, Modena
Novartis Investigative Site, Wuppertal
Novartis Investigative Site, Warren
Novartis Investigative Site, Bochum
Novartis Investigative Site, Bochum
Novartis Investigative Site, Essen
Novartis Investigative Site, Recklinghausen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, Krefeld
Novartis Investigative Site, Ann Arbor
Novartis Investigative Site, Münster
Novartis Investigative Site, Osnabrück
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Busan
Novartis Investigative Site, Cologne
Novartis Investigative Site, Tartu
Novartis Investigative Site, Reims
Novartis Investigative Site, Bonn
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Gwangju
Novartis Investigative Site, Hanau
Novartis Investigative Site, Darmstadt
Novartis Investigative Site, Topeka
Novartis Investigative Site, Omaha
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Dallas
Novartis Investigative Site, Paris
Novartis Investigative Site, Houston
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Austin
Novartis Investigative Site, München
Novartis Investigative Site, Colorado Springs
Novartis Investigative Site, Salt Lake City
Novartis Investigative Site, Phoenix
Novartis Investigative Site, Phoenix
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Pasadena
Novartis Investigative Site, Oceanside
Novartis Investigative Site, San Diego
Novartis Investigative Site, San Diego
Novartis Investigative Site, Klaipėda
Novartis Investigative Site, Catania
Novartis Investigative Site, Oregon City
Novartis Investigative Site, Portland
Novartis Investigative Site, Portland
Novartis Investigative Site, Erfurt
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Singapore
Novartis Investigative Site, Afula
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Johnston
Novartis Investigative Site, Dallas
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Mendoza
Novartis Investigative Site, Edmonton
Novartis Investigative Site, Surrey
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Moncton
Novartis Investigative Site, Halifax
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Markham
Novartis Investigative Site, Peterborough
Novartis Investigative Site, Richmond Hil
Novartis Investigative Site, Waterloo
Novartis Investigative Site, Montreal
Novartis Investigative Site, Sainte-Foy
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Taoyuan District
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Nice
Novartis Investigative Site, Dresden
Novartis Investigative Site, Gera
Novartis Investigative Site, Plauen
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Szeged
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Kurume
Novartis Investigative Site, Maebashi
Novartis Investigative Site, Asahikawa
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Kobe
Novartis Investigative Site, Inashiki-gun
Novartis Investigative Site, Isehara
Novartis Investigative Site, Kawasaki
Novartis Investigative Site, Sagamihara
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Chiyoda-ku
Novartis Investigative Site, Minato-ku
Novartis Investigative Site, Shinagawa-ku
Novartis Investigative Site, Shinjuku-ku
Novartis Investigative Site, Shinjuku-ku
Novartis Investigative Site, Daugavpils
Novartis Investigative Site, Ventspils
Novartis Investigative Site, Riga
Novartis Investigative Site, Kaunas
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Lodz
Novartis Investigative Site, Lodz
Novartis Investigative Site, Poznan
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Santa Coloma de Gramanet
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Malmo
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Plymouth
Novartis Investigative Site, London
Novartis Investigative Site, Salford
Novartis Investigative Site, Yeovil
Novartis Investigative Site, Dudley
Novartis Investigative Site, Harrogate
Novartis Investigative Site, Nuneaton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY